332 related articles for article (PubMed ID: 23810430)
1. Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.
Haas M; Ben-Moshe I; Fischer B; Reiser G
Biochem Pharmacol; 2013 Sep; 86(5):645-55. PubMed ID: 23810430
[TBL] [Abstract][Full Text] [Related]
2. Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.
Tulapurkar ME; Laubinger W; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2004 Jul; 142(5):869-78. PubMed ID: 15197109
[TBL] [Abstract][Full Text] [Related]
3. Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.
Ecke D; Tulapurkar ME; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2006 Oct; 149(4):416-23. PubMed ID: 16953187
[TBL] [Abstract][Full Text] [Related]
4. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the human P2Y11 receptor.
Communi D; Robaye B; Boeynaems JM
Br J Pharmacol; 1999 Nov; 128(6):1199-206. PubMed ID: 10578132
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
7. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
[TBL] [Abstract][Full Text] [Related]
8. 5-OMe-uridine-5'-O-(α-boranodiphosphate), a novel nucleotide derivative highly active at the human P2Y(6) receptor protects against death-receptor mediated glial apoptosis.
Haas M; Ginsburg-Shmuel T; Fischer B; Reiser G
Neurosci Lett; 2014 Aug; 578():80-4. PubMed ID: 24970757
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of P2Y receptor subtypes on isolated tiger salamander Müller cells.
Reifel Saltzberg JM; Garvey KA; Keirstead SA
Glia; 2003 Apr; 42(2):149-59. PubMed ID: 12655599
[TBL] [Abstract][Full Text] [Related]
10. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
Kauffenstein G; Hechler B; Cazenave JP; Gachet C
J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
[TBL] [Abstract][Full Text] [Related]
11. The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery.
Malmsjö M; Adner M; Harden TK; Pendergast W; Edvinsson L; Erlinge D
Br J Pharmacol; 2000 Sep; 131(1):51-6. PubMed ID: 10960068
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of a novel cyclic AMP-linked P2 receptor on undifferentiated HL-60 leukemia cells.
Conigrave AD; Lee JY; van der Weyden L; Jiang L; Ward P; Tasevski V; Luttrell BM; Morris MB
Br J Pharmacol; 1998 Aug; 124(7):1580-5. PubMed ID: 9723974
[TBL] [Abstract][Full Text] [Related]
13. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
Boyer JL; Lazarowski ER; Chen XH; Harden TK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
[TBL] [Abstract][Full Text] [Related]
14. Identification of competitive antagonists of the P2Y1 receptor.
Boyer JL; Romero-Avila T; Schachter JB; Harden TK
Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
[TBL] [Abstract][Full Text] [Related]
15. An examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor.
Schachter JB; Harden TK
Br J Pharmacol; 1997 May; 121(2):338-44. PubMed ID: 9154346
[TBL] [Abstract][Full Text] [Related]
16. Adenosine 5'-(gamma-thio) triphosphate (ATPgammaS) stimulates both P2Y receptors linked to inositol phosphates production and cAMP accumulation in bovine adrenocortical fasciculata cells.
Nishi H; Hori S; Niitsu A; Kawamura M
Life Sci; 2004 Jan; 74(9):1181-90. PubMed ID: 14687658
[TBL] [Abstract][Full Text] [Related]
17. Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
Nahum V; Zündorf G; Lévesque SA; Beaudoin AR; Reiser G; Fischer B
J Med Chem; 2002 Nov; 45(24):5384-96. PubMed ID: 12431066
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.
Guns PJ; Korda A; Crauwels HM; Van Assche T; Robaye B; Boeynaems JM; Bult H
Br J Pharmacol; 2005 Sep; 146(2):288-95. PubMed ID: 15997227
[TBL] [Abstract][Full Text] [Related]
19. Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions.
Wildman SS; Unwin RJ; King BF
Br J Pharmacol; 2003 Dec; 140(7):1177-86. PubMed ID: 14581177
[TBL] [Abstract][Full Text] [Related]
20. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.
Farret A; Filhol R; Linck N; Manteghetti M; Vignon J; Gross R; Petit P
Pharm Res; 2006 Nov; 23(11):2665-71. PubMed ID: 17048117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
